Jukyung Kang

Characterization of apolipoprotein A-I peptide phospholipid interaction and its effect on HDL nanodisc assembly

A. Schwendeman, Lei Shen, Zhan Chen, 2019, International journal of nanomedicine.

Assessment of biosimilarity under native and heat-stressed conditions: rituximab, bevacizumab, and trastuzumab originators and biosimilars

B. Ruotolo, A. Schwendeman, Zeynab Izadi Najafabadi, 2019, Analytical and Bioanalytical Chemistry.

High‐Density Lipoprotein in Lupus: Disease Biomarkers and Potential Therapeutic Strategy

M. Kaplan, A. Schwendeman, Minzhi Yu, 2020, Arthritis & rheumatology.

The Effects of pH and Excipients on Exenatide Stability in Solution

S. Schwendeman, A. Schwendeman, Rose Ackermann, 2021, Pharmaceutics.

Characterization of Attributes and in vitro Performance of Exenatide-loaded PLGA Long-acting Release Microspheres.

S. Schwendeman, Avital Beig, Yan Wang, 2020, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Physicochemical Characterization and Functionality Comparison of Humira®(adalimumab), Remicade®(infliximab) and Simponi Aria®(golimumab).

A. Schwendeman, Michael Ford, Jukyung Kang, 2023, International journal of pharmaceutics.

Multifaceted assessment of rituximab biosimilarity: The impact of glycan microheterogeneity on Fc function.

B. Ruotolo, D. Weis, S. Schwendeman, 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Biosimilarity under stress: A forced degradation study of Remicade® and Remsima™

B. Ruotolo, S. Schwendeman, S. Saveliev, 2017, mAbs.

Collision-Induced Unfolding Reveals Stability Differences in Infliximab Therapeutics under Native and Heat Stress Conditions.

Daniel A. Polasky, B. Ruotolo, A. Schwendeman, 2021, Analytical chemistry.